Literature DB >> 4847438

Aortic lymph node metastases in early ovarian cancer.

R C Knapp, E A Friedman.   

Abstract

Entities:  

Mesh:

Year:  1974        PMID: 4847438     DOI: 10.1016/0002-9378(74)90251-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  7 in total

Review 1.  Ovarian tumors. A review.

Authors:  R E Scully
Journal:  Am J Pathol       Date:  1977-06       Impact factor: 4.307

2.  [Surgical therapy of ovarian cancer].

Authors:  A Pfleiderer
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

3.  Does omentectomy prevent malignant small bowel obstruction?

Authors:  J L Weese; F D Ottery; S E Emoto
Journal:  Clin Exp Metastasis       Date:  1988 Jul-Aug       Impact factor: 5.150

4.  What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.

Authors:  Bunja J Rungruang; Austin Miller; Thomas C Krivak; Neil S Horowitz; Noah Rodriguez; Chad A Hamilton; Floor J Backes; Linda F Carson; Michael Friedlander; David G Mutch; Michael J Goodheart; Krishnansu S Tewari; Robert M Wenham; Michael A Bookman; G Larry Maxwell; Scott D Richard
Journal:  Cancer       Date:  2016-11-16       Impact factor: 6.860

5.  Early diagnosis of ovarian cancer.

Authors:  D R Popkin
Journal:  Can Med Assoc J       Date:  1979-05-05       Impact factor: 8.262

6.  Sarcoma-like mural nodules in cystic serous ovarian tumours.

Authors:  T J Clarke
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

7.  Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer.

Authors:  Su-Jin Baek; Jeong-Yeol Park; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2008-12-29       Impact factor: 4.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.